Clinical AI Opportunity BioSerenity focuses on connected medical solutions for neurology, sleep disorders and cardiology, leveraging AI and digital biomarkers to aid diagnosis and monitoring. Sales opportunities exist in expanding AI-enabled decision support tools and automated EEG analysis with hospitals and health networks seeking to improve diagnostic throughput and reduce neurologist workload.

Hospital Network Expansion With over 200 European hospitals already adopting their platform and diagnosing over a hundred thousand patients annually, there is upside in onboarding additional hospitals and regional health systems, particularly where there are shortages of specialists, to scale adoption of their IoT sensors, platforms and ESG data practices.

Strategic Partnerships Recent collaborations with Stratusneuro and private equity investment indicate a growth trajectory and ecosystem-building potential. There is a sales opening to formalize partnerships with neurodiagnostic providers, device manufacturers, and academic medical centers to broaden distribution, integration, and co-development opportunities.

IP and Compliance Edge BioSerenity operates with ISO 13485 and has an established tech stack for secure, compliant medical deployments. A proactive sales angle is offering compliant, scalable deployments to healthcare customers requiring regulatory alignment, data governance, and interoperability with ELK, JSON-LD and other standards.

Global Growth Funding Significant funding activity, including a $120M funding base and a €24M investment from JOLT Capital, signals financial backing for large-scale deployments and platform enhancements. Opportunities exist to pitch expanded product lines, premium analytics features, and performance-based pricing to high-potential hospital networks and regional health authorities.